Symptom Experiences and Coping Strategies in Turkish Patients with Implantable Cardioverter-Defibrillators: A

Sebiha Aktaş Us1, Sultan Taşcı2

  • 1Public Hospital Services Unit, Sinop Provincial Health Directorate, Turkish Ministry of Health, 57000 Sinop, Türkiye.

PubMed

Background/Objectives: Although implantable cardioverter defibrillators (ICDs) play a critical role in reducing the risk of sudden cardiac death, patients may report various physical and psychological symptoms during the implantation process. This study aimed to examine ICD patients' retrospective reports of pre-implantation symptoms, their concurrent assessment of post-implantation symptom experiences, and the non-pharmacological methods they used to cope with these symptoms. Methods: A cross-sectional study was conducted with ICD patients who visited the arrhythmia clinic between May and August 2022. Data were collected using a questionnaire developed by the researchers and medical records. The study analyzed changes in symptoms reported by patients, individual coping methods used, the perceived effectiveness of these methods, and comparisons of methods used according to descriptive and clinical characteristics. Results: Patients reported a decrease in chest pain, palpitations, dizziness, syncope, and shortness of breath after ICD implantation (p < 0.001). However, they reported an increase in fatigue and anxiety levels (p < 0.001); no significant change was reported for insomnia (p = 0.473) and fear (p = 0.082). Furthermore, no significant difference was observed between patients who received shock therapy and those who did not in terms of changes in anxiety and fatigue levels, and the increase in anxiety was similar in both groups. The most frequently reported coping method among patients was praying, followed by drinking herbal tea and walking. A significant relationship was found between marital status and coping method preference, while no relationship was found with other descriptive and clinical characteristics. Conclusions: Although ICD implantation reduces cardiac symptoms, anxiety and fatigue continue to increase. Patients' tendency to turn to cultural and spiritual coping methods such as prayer indicates that post-ICD care should be conducted with a holistic approach that also covers psychological and spiritual needs.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
326
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
455
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
387
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
245
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
317
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
746